AMED’s “CANNDs” Set for Full Rollout in FY2023, but Panel Members Want Wider Range of Data to Fuel Drug Discovery

The Japan Agency for Medical Research and Development (AMED) plans to fully launch its integrated data platform, dubbed CANNDs, in FY2023, but government panel members are calling for expanding the range of data to promote its use for drug discovery...read more